BioEcho Life Sciences, a leading provider of innovative molecular biology solutions, announces the launch of its eChoLution FFPE RNA Kit, which provides researchers with a simplified protocol and excellent RNA quality for their studies. The extracted RNA can be used directly for RT-qPCR and provides reliable results. Used in total transcriptome sequencing (RNA-seq), RNA produces demonstrably better results, as more unique mappers and more genes are recognized than with established kits. This opens up new opportunities for transcriptomic studies and improves the understanding of complex biological processes. In addition to the technical advantages, the EchoLution FFPE RNA Kit also offers environmental benefits: By reducing plastic waste and hazardous reagents to a minimum, the kit's ecological footprint is minimized.

“We are thrilled to present the eCHolution FFPE RNA kit to the scientific community,” explains Dr. Thomas Neumann, Chief Commercial Officer & President of the US subsidiary BioEcho, Inc.” This innovative solution not only simplifies the RNA extraction process, but also provides the highest quality RNA for downstream applications. We are convinced that this kit will significantly improve researchers' ability to research diseases and contribute to advances in the field of molecular biology.”

FFPE tissue samples are an invaluable source of data for researching diseases. However, their analysis is a major challenge due to the associated fixing and preservation processes. Traditional workflows are cumbersome, time-consuming, and often require the use of hazardous reagents. In contrast to conventional methods, which require lengthy incubations and numerous work steps, the EchoLution FFPE RNA Kit enables RNA extraction in a single step after the formalin cross-connections and paraffin have been removed. This not only saves valuable time, but also allows the RNA to flow unaffected through the purification matrix, which simplifies the process and makes it more user-friendly.

About BioEchoLife Sciences GmbH

BioEcho LifeSciences is a specialized solution provider for nucleic acid extraction and analysis. We develop disruptive technologies, products and workflows that make the processing of nucleic acids significantly easier and faster, significantly increase throughput and deliver reliable results. In just one step, our EchoLution™ technology enables the fastest DNA and RNA extraction on the market and drastically reduces the associated plastic waste.

BioEcho was founded in 2016 by leading industry experts. The company has its headquarters in Cologne, which is certified according to ISO 9001 and ISO 13485.

‍

BioEcho. The Nucleic Acid Experts.

www.bioecho.de

Contact for press inquiries:

Dr. Laura Torres Benito, Scientific Communications Manager

Office: +49 221998897-24

E-mail: laura.torres.benito@bioecho.de

BioEcho Life Sciences, a leading provider of innovative molecular biology solutions, announces the launch of its eChoLution FFPE RNA Kit, which provides researchers with a simplified protocol and excellent RNA quality for their studies. The extracted RNA can be used directly for RT-qPCR and provides reliable results. Used in total transcriptome sequencing (RNA-seq), RNA produces demonstrably better results, as more unique mappers and more genes are recognized than with established kits. This opens up new opportunities for transcriptomic studies and improves the understanding of complex biological processes. In addition to the technical advantages, the EchoLution FFPE RNA Kit also offers environmental benefits: By reducing plastic waste and hazardous reagents to a minimum, the kit's ecological footprint is minimized.

“We are thrilled to present the eCHolution FFPE RNA kit to the scientific community,” explains Dr. Thomas Neumann, Chief Commercial Officer & President of the US subsidiary BioEcho, Inc.” This innovative solution not only simplifies the RNA extraction process, but also provides the highest quality RNA for downstream applications. We are convinced that this kit will significantly improve researchers' ability to research diseases and contribute to advances in the field of molecular biology.”

FFPE tissue samples are an invaluable source of data for researching diseases. However, their analysis is a major challenge due to the associated fixing and preservation processes. Traditional workflows are cumbersome, time-consuming, and often require the use of hazardous reagents. In contrast to conventional methods, which require lengthy incubations and numerous work steps, the EchoLution FFPE RNA Kit enables RNA extraction in a single step after the formalin cross-connections and paraffin have been removed. This not only saves valuable time, but also allows the RNA to flow unaffected through the purification matrix, which simplifies the process and makes it more user-friendly.

About BioEchoLife Sciences GmbH

BioEcho LifeSciences is a specialized solution provider for nucleic acid extraction and analysis. We develop disruptive technologies, products and workflows that make the processing of nucleic acids significantly easier and faster, significantly increase throughput and deliver reliable results. In just one step, our EchoLution™ technology enables the fastest DNA and RNA extraction on the market and drastically reduces the associated plastic waste.

BioEcho was founded in 2016 by leading industry experts. The company has its headquarters in Cologne, which is certified according to ISO 9001 and ISO 13485.

‍

BioEcho. The Nucleic Acid Experts.

www.bioecho.de

Contact for press inquiries:

Dr. Laura Torres Benito, Scientific Communications Manager

Office: +49 221998897-24

E-mail: laura.torres.benito@bioecho.de